Sterling bounce could present short window With the pound packing a punch a sell against yen could be in order
Synthomer sell-off could be an opportunity Tough European end markets should not blind traders to Asian growth
Dialight opportunity shines brightly Several new contracts on the cards after landmark North American win
Conviviality Retail could prove a bargain New Aim company offers compelling play on cut-price booze and convenience trends
Aussie dollar under pressure from dire economy As macro-economic newsflow down under deteriorates currency feels the heat
Demolition risk to Balfour forecasts Market remains too optimistic that worst is behind the infrastructure giant
Vertu is stepping on the gas Further forecast upgrades to drive upwards momentum behind the acquisitive motor dealer
Stitch Fiberweb into your portfolio Self-help measures and hints of stronger markets bode well for fabrics group
Biotech Blockbusters Where there is risk there is reward and nowhere does this apply more than to biotechnology companies. Mark Dunne puts the sector under the microscope and discovers a quintet of portfolio-enhancing firms.
Why Aim is bang on target for technology companies Market provides the perfect environment for innovative firms to grow
QE’s demise - a positive for portfolio diversification? In his second article about the implications of tighter US monetary policy, Simon Keane asks if trusted correlations could re-emerge as quantitative easing is withdrawn
Preparing for a bright future Amid regulatory changes we look at the benefits of using a Sipp to build a retirement nest egg
Best of British Part IV: The Midlands Dan Coatsworth raises a glass to metal bashers, pharmas and tech enablers as he unearths the region’s best quoted firms
